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Many factors are involved in our ability to understand the complex role of the
blood recipient in cytomegalovirus infections. The age factor is an extremely im-
portant one. The neonate does not have a fully developed immunological system and
is not able to respond as well as the mature individual. The young child has an intact
immune system but has had only limited experience with infectious agents. In
general, the adult is both experienced and immunologically competent. At the far
end of the age scale is the geriatric patient who, though experienced antigenically
may not be as immunologically competent as during more vigorous adult years.
Another factor is that of health versus disease. A few patients are transfused
secondary to trauma; but the majority of patients are acutely ill, chronically ill, or
both. The nature of the underlying illness is obviously very important in the
recipient's response to blood and agents contained therein. For instance, the
Hodgkin's disease patient with a defect in cellular-immune capacity would not be ex-
pected to deal as effectively with infectious agents within the transfused blood as
would a more normal individual.
Also related to the problem of recipient response is the particular treatment
regimen given to the patient. Obviously, some recipients are on no therapy at all and
thus do not have a compromised ability to react to any blood-borne agents. On the
other hand, a number of patients are on steroids, antitumor drugs, and immunosup-
pressants, or combinations ofthe above. The latter patients would not be expected to
react as effectively as would the normal mature patient. These arejust a few of the
gross parameters which make studies of recipient response difficult. The complex
interaction among the factors involved makes it difficult to generalize and necessi-
tatesindividualization ofeach patient involved.
Historically, as far as the question of recipient response to specific cytomegalovi-
rus (CMV) transmission by blood is concerned, Kreel et al. (3) in 1960 described a
syndrome offever, splenomegaly, and atypical lymphocytosis with a negative hetero-
phile which occurred after extracorporeal circulation for open-heart surgery. The
onset was usually 3 to 7 weeks postperfusion. Kaariainen et al. (2) and later Lang et
al. (4) and Foster and Jack (1) implicated CMV both serologically and virologically in
this type ofpatient. They also agreed that blood transfusion was highly suspect as the
mechanism of transmission of the virus. It was also appreciated that there was a
close resemblance between this postperfusion syndrome and the previously described
CMV mononucleosis. Today the postperfusion syndrome is a well described entity
which occurs in 3-1 1% ofpatients undergoing open-heart surgery (4). CMV infection
in these recipients, however, is much more common ranging upwards from 33% of
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those undergoing this particular procedure (5). Cultures of CMV from leukocytes
raised the question of risk, and studies by Prince et al. (6) seemed to indicate that
there was a direct relation between the number of units transfused and the risk of
CMV infection. The risk was approximately 5% per unit transfused, and neither use
of fresh blood nor the antibody status of the recipient seemed to be a determining
factor.
At about the same time, CMV was implicated as a causative problem in renal
transplants, supposedly being involved in generalized infection, interstitial pneu-
monia, and possibly the rejection ofthe transplant. However, most oftheseinfections
are probably asymptomatic, and the problem ofinterpreting their roleis complicated
by the use ofsteroids and immunosuppressants in the recipient.
The mode of acquisition of the CMV infection is also a particularly vexing prob-
lem. The virus could be acquired from exogenous sources such as the environment,
the transfused blood, or the donated kidney. On the other hand, it's quite possible
that the virus is acquired endogenously or by reactivation of a virus already present
in the recipient at the time of transplantation. The assumption has commonly been
made that those recipients that are seronegative to CMV at the time of transplant
probably acquire their infection exogenously, whereas those individuals who are se-
ropositive at the time of transplant acquire their infection by reactivation, or
endogenously. For several reasons, there is no real proof that this assumption is cor-
rect. There is a question ofthe sensitivity ofthe antibody tests used to detect CMV,
be it complement fixation, immunofluorescence, indirect hemagglutination, or some
other more sophisticated technique. In addition, there is evidence to indicate that a
person may have antibody at one point in time and then over the course ofmonths to
years lose that antibody, appear to be antibody negative and then, once again,
manifest the presence of antibody. Since there are a number of CMV strains, com-
plete reliability ofantibody tests using any one particular strain as an antigen is ques-
tionable.
We have been studying babies undergoing exchange transfusion in attempt to shed
more light on this problem of endogenous versus exogenous sources ofinfection. We
theorized that an infant who was antibody negative at the time of exchange transfu-
sion would have had little, ifany, chance to have lost previously existing antibody and
thus would constitute a truly susceptible individual without previous experience with
CMV. In addition, we were interested in knowing the risk of acquiring CMV infec-
tion as well as any symptoms and signs which might accompany acquisition of this
particular agent. Babies, mothers, and blood donors were studied serologically and
virologically before transfusion, as well as 6 and 12 weeks post-transfusion. The
serological studies consisted of complement fixation (CF) antibody determinations,
while virological studies consisted of cultures of throat, urine, and buffy coat at the
time ofexchange transfusion and follow-up cultures 6 and 12 weeks later. Control in-
fants matched for age, sex, weight, and race together with control mothers were
evaluated in a similar manner to the study infants, except that buffy-coat cultures
were not done. Studies have been completed on 24 babies who have undergone at
least one exchange transfusion. These babies have received a total of 34 units of
blood. Six infants were antibody negative before exchange transfusion, and 18 infants
were antibody positive; no infants were culture positive at the timeofexchange trans-
fusion. Of the 20 infants in the control group, 11 were antibody positive and none
were culture positive. The results are shown in Table 1. Five of the study infants be-
came infected with cytomegalovirus 6 to 12 weeks after exchange transfusion. Ofthe
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TABLE 1
CMV Infection in Transfused Patients
Antibody status Antibody status ofdonor blood
ofrecipient prior
to transfusion Negative Positive Total
Negative 1/4 a 1/2 2/6
Positive 0/6 3/12 3/18
1/10 4/14 5/24
aThe fractions represent number infected/number in category.
six infants who were antibody negative, two received blood from antibody-positive
donors and one of these became infected. Four infants received blood from antibody
negative donors, and one of these became infected. Of the 18 infants who were anti-
body positive, 12 received blood from antibody-positive donors and three became
infected. Six patients received blood from antibody-negative donors and none became
infected. None ofthe control infants became infected during the study period; and all
ofthe infants, regardless ofwhether they became infected or not, remained asympto-
matic, and their CBC's remained within normal limits. One mother of a transfused
infant developed cytomegaloviruria, but the child remained negative. All cultures
from control mothers and blood donors remained negative. In summary, 21% of ex-
change-transfused infants became infected, transplacental antibody was not protec-
tive, a donor with complement-fixation antibody was somewhat more likely to be the
source of infection than an antibody-negative donor, and no clinical disease was de-
tected in this particular study population. These data strongly suggest that cytomeg-
alovirus infection may be transmitted by blood transfusion even though it is not possi-
ble to culture virus from the blood used, and that acquisition ofinfection, at least in
this small numberofpatients, is most likely to be asymptomatic.
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